Entasis

FDA schedules adcomms for Entasis' antimicrobial treatment, Intercept's NASH hopeful
Endpoints
Mon, 03/13/23 - 10:19 am
FDA
Entasis
Intercept Pharma
sulbactam-durlobactam
obeticholic acid
NASH
Experimental treatment appears effective against gonorrhea in small study
Stat
Wed, 11/7/18 - 07:05 pm
gonorrhea
antibiotics
zoliflodacin
Entasis
Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
Endpoints
Thu, 09/27/18 - 11:55 am
NASDAQ
IPOs
Entasis
Urovant Sciences
Arvinas
Sutro BioPharma
Entasis dips in first trading day after $75M IPO
BioCentury
Wed, 09/26/18 - 07:26 pm
IPOs
AstraZeneca
Entasis
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
Fierce Biotech
Mon, 08/20/18 - 10:09 am
Entasis
IPOs
AstraZeneca
clinical trials
beta-lactams
Whittled down to biotech size, AstraZeneca's antibiotics crew starts over as Entasis
Fierce Biotech
Wed, 07/1/15 - 10:41 am
AstraZeneca
antibiotics
Entasis
R&D